Alzamend Neuro (ALZN) Change in Account Payables (2020 - 2023)

Alzamend Neuro has disclosed Change in Account Payables across 4 years of filings, most recently posting $227649.0 for Q2 2023.

• In Q2 2023, Change in Account Payables fell 70.07% year-over-year to $227649.0; the TTM figure through Apr 2023 stood at $1.7 million (up 146.15% YoY), while the FY2023 annual figure was $1.7 million, up 146.15% from the prior year.
• Change in Account Payables came in at $227649.0 for Q2 2023 at Alzamend Neuro, down from $2.0 million in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $2.0 million in Q1 2023 to a low of -$613257.0 in Q1 2022.
• Average Change in Account Payables over 4 years is $165634.5, with a median of $69838.0 recorded in 2020.
• Year-over-year, Change in Account Payables plunged 1564.61% in 2022 and soared 425.21% in 2023.
• Over 4 years, Change in Account Payables stood at $162414.0 in 2020, then slumped by 114.0% to -$22738.0 in 2021, then tumbled by 1564.61% to -$378499.0 in 2022, then jumped by 160.15% to $227649.0 in 2023.
• Per Business Quant data, the three most recent Change in Account Payables figures were $227649.0 in Q2 2023, $2.0 million in Q1 2023, and -$378499.0 in Q4 2022.